Literature DB >> 19420388

Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus.

Armina A Kazi1, Kristin Happ Molitoris, Robert D Koos.   

Abstract

We have previously shown that 17beta-estradiol (E(2)) increases vascular endothelial growth factor A (Vegfa) gene expression in the rat uterus, resulting in increased microvascular permeability, and that this involves the simultaneous recruitment of hypoxia-inducible factor 1 (HIF1) and estrogen receptor alpha (ESR1) to the Vegfa gene promoter. Both events require the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway. However, those studies were carried out using whole uterine tissue, and while most evidence indicates that the likely site of E(2)-induced Vegfa expression is luminal epithelial (LE) cells, other studies have identified stromal cells as the site of that expression. To address this question, the pathway regulating Vegfa expression was reexamined using LE cells rapidly isolated after E(2) treatment. In addition, we further characterized the nature of the receptor through which E(2) triggers the signaling events that lead to Vegfa expression using the specific ESR1 antagonist ICI 182,780. In agreement with previous results in the whole uterus, E(2) stimulated Vegfa mRNA expression in LE cells, peaking at 1 h (4- to 14-fold) and returning to basal levels by 4 h. Treatment with E(2) also increased phosphorylation of AKT in LE cells, as well as of the downstream mediators FRAP1 (mTOR), GSK3B, and MDM2. The alpha subunit of HIF1 (HIF1A) was present in LE cells before E(2) treatment, was unchanged 1 h after E(2), but was >2-fold higher by 4 h. Chromatin immunoprecipitation analysis showed that HIF1A was recruited to the Vegfa promoter by 1 h and was absent again by 4 h. The E(2) activation of the PI3K/AKT pathway, HIF1A recruitment to the Vegfa promoter, and Vegfa expression were all blocked by ICI 182,780. In summary, the rapid E(2)-induced signaling events that lead to the expression of Vegfa observed previously using the whole uterus occur in LE cells and appear to be initiated via a membrane form of ESR1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19420388      PMCID: PMC2849827          DOI: 10.1095/biolreprod.109.076117

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  93 in total

1.  Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus.

Authors:  W Ma; J Tan; H Matsumoto; B Robert; D R Abrahamson; S K Das; S K Dey
Journal:  Mol Endocrinol       Date:  2001-11

2.  Paracrine signaling through the epithelial estrogen receptor alpha is required for proliferation and morphogenesis in the mammary gland.

Authors:  Sonia Mallepell; Andrée Krust; Pierre Chambon; Cathrin Brisken
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-01       Impact factor: 11.205

3.  Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.

Authors:  Nianli Sang; Jie Fang; Vickram Srinivas; Irene Leshchinsky; Jaime Caro
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

4.  An essential role for p300/CBP in the cellular response to hypoxia.

Authors:  Z Arany; L E Huang; R Eckner; S Bhattacharya; C Jiang; M A Goldberg; H F Bunn; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

5.  2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.

Authors:  Christian M Becker; Nadine Rohwer; Tae Funakoshi; Thorsten Cramer; Wanja Bernhardt; Amy Birsner; Judah Folkman; Robert J D'Amato
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

Review 6.  PI3K/PTEN signaling in tumorigenesis and angiogenesis.

Authors:  Bing-Hua Jiang; Ling-Zhi Liu
Journal:  Biochim Biophys Acta       Date:  2007-09-29

7.  p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).

Authors:  Tobias Schmid; Jie Zhou; Roman Köhl; Bernhard Brüne
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

8.  BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.

Authors:  Matthias Mayerhofer; Peter Valent; Wolfgang R Sperr; James D Griffin; Christian Sillaber
Journal:  Blood       Date:  2002-07-18       Impact factor: 22.113

9.  Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand.

Authors:  Heather A Harris; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Endocrinology       Date:  2002-11       Impact factor: 4.736

10.  Tissue- and hormone-dependent progesterone receptor distribution in the rat uterus.

Authors:  Lena Sahlin; Britt Masironi; Sonja Akerberg; Håkan Eriksson
Journal:  Reprod Biol Endocrinol       Date:  2006-09-11       Impact factor: 5.211

View more
  39 in total

1.  Xtalk: a path-based approach for identifying crosstalk between signaling pathways.

Authors:  Allison N Tegge; Nicholas Sharp; T M Murali
Journal:  Bioinformatics       Date:  2015-09-23       Impact factor: 6.937

2.  Exposure to ionizing radiation causes long-term increase in serum estradiol and activation of PI3K-Akt signaling pathway in mouse mammary gland.

Authors:  Shubhankar Suman; Michael D Johnson; Albert J Fornace; Kamal Datta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-28       Impact factor: 7.038

3.  Phosphorylation of AKT and abdominal aortic aneurysm formation.

Authors:  Abhijit Ghosh; Guanyi Lu; Gang Su; Brendan McEvoy; Omar Sadiq; Paul D DiMusto; Adriana Laser; John S Futchko; Peter K Henke; Jonathan L Eliason; Gilbert R Upchurch
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

4.  Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival.

Authors:  Jibran Sualeh Muhammad; Khuloud Bajbouj; Jasmin Shafarin; Mawieh Hamad
Journal:  Epigenetics       Date:  2020-06-01       Impact factor: 4.528

5.  Gene expression changes and promoter methylation with the combined effects of estradiol and leptin in uterine tissue of the ovariectomized mice model of menopause.

Authors:  Abhishek Shetty; Thejaswini Venkatesh; Rie Tsutsumi; Padmanaban S Suresh
Journal:  Mol Biol Rep       Date:  2019-10-10       Impact factor: 2.316

6.  SASH1 inhibits proliferation and invasion of thyroid cancer cells through PI3K/Akt signaling pathway.

Authors:  Dawei Sun; Rui Zhou; Huamin Liu; Wenhai Sun; Anbing Dong; Hongmei Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  The induction of pro-angiogenic processes within a collagen scaffold via exogenous estradiol and endometrial epithelial cells.

Authors:  Jacquelyn C Pence; Kathryn B H Clancy; Brendan A C Harley
Journal:  Biotechnol Bioeng       Date:  2015-07-22       Impact factor: 4.530

8.  Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells.

Authors:  Chun-Chung Lee; Ko-Jiunn Liu; Yu-Chen Wu; Sue-Jane Lin; Ching-Chun Chang; Tze-Sing Huang
Journal:  Inflammation       Date:  2011-06       Impact factor: 4.092

9.  HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland.

Authors:  N Ogba; Y Q Doughman; L J Chaplin; Y Hu; M Gargesha; M Watanabe; M M Montano
Journal:  Oncogene       Date:  2010-05-10       Impact factor: 9.867

Review 10.  Genetic and neuroendocrine regulation of the postpartum brain.

Authors:  Stephen C Gammie; Terri M Driessen; Changjiu Zhao; Michael C Saul; Brian E Eisinger
Journal:  Front Neuroendocrinol       Date:  2016-05-13       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.